Senate Bill 1715 Summary

• Defines "hemp-derived manufactured impairing cannabinoids" as cannabinoids derived from hemp and chemically altered to create impairing properties, specifically including delta-8 and delta-10 tetrahydrocannabinol, hexahydrocannabinol, tetrahydrocannabiphoral, and tetrahydrocannabinol acetate ester.

• Prohibits nonprofit medical marijuana dispensaries and marijuana establishments from acquiring, cultivating, possessing, manufacturing, delivering, processing, transferring, transporting, supplying, using, selling, or dispensing hemp-derived manufactured impairing cannabinoids.

• Excludes hemp-derived manufactured impairing cannabinoids from the definition of industrial hemp in the state's agricultural pilot program.

• Authorizes the attorney general to investigate and take action against the sale, marketing, and distribution of hemp-derived manufactured impairing cannabinoids, with funding allocation from the smart and safe Arizona fund.

• Requires a three-fourths affirmative vote of both legislative houses for the marijuana-related amendments to become effective, pursuant to Arizona's constitutional requirements.